Nebenwirkungen · Advate
ADVATE 250 IU/2 ml powder and solvent for solution for injection ADVATE 500 IU/2 ml powder and solvent for solution for injection ADVATE 1 000 IU/2 ml powder and solvent for solution for injection ADVATE 1 500 IU/2 ml powder and solvent for solution for injection · Abschnitt 4.8 · PDF-Seite 19
HOS-112462 · Präparat HOS-093675
Hypersensitivity or allergic reactions (which may include angioedema, burning and stinging at the infusion site, chills, flushing, generalised urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing) have been observed rarely and may in some cases progress to severe anaphylaxis (including shock).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-05-23T12:20:00Z · SHA-256 1676714d819bb0bd275e9f7e4eb6349a64035cde34acd2a9aa639c8e0ad4123b · Passage 7d6a609bd724d3a05a27d6669707425305daa275a404ef9a2e1d0af3b72ecde4 · Zeichen 314–694 im Abschnitt